BIT
SRPT icon

BlackRock Institutional Trust’s Sarepta Therapeutics SRPT Stock Holding History

BlackRock Institutional Trust’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$35.8M Buy
1,306,520
+199,401
+18% +$8.01M 0.01% 1551
2016
Q3 		$68M Buy
1,107,119
+58,501
+6% +$1.77M 0.01% 1104
2016
Q2 		$20M Sell
1,048,618
-20,295
-2% -$376K ﹤0.01% 1849
2016
Q1 		$20.9M Buy
1,068,913
+25,799
+2% +$451K ﹤0.01% 1804
2015
Q4 		$40.2M Buy
1,043,114
+106,965
+11% +$3.47M 0.01% 1395
2015
Q3 		$30.1M Sell
936,149
-172,167
-16% -$5.84M 0.01% 1553
2015
Q2 		$33.7M Sell
1,108,316
-60,583
-5% -$1.24M 0.01% 1556
2015
Q1 		$15.5M Buy
1,168,899
+295
+0% +$3.93K ﹤0.01% 2108
2014
Q4 		$16.9M Buy
1,168,604
+91,835
+9% +$1.56M ﹤0.01% 2013
2014
Q3 		$22.7M Buy
1,076,769
+9,553
+0.9% +$216K ﹤0.01% 1793
2014
Q2 		$31.8M Buy
1,067,216
+31,706
+3% +$1M 0.01% 1635
2014
Q1 		$24.9M Buy
1,035,510
+40,667
+4% +$1.04M ﹤0.01% 1814
2013
Q4 		$20.3M Buy
994,843
+91,009
+10% +$2.7M ﹤0.01% 1932
2013
Q3 		$42.7M Buy
903,834
+48,706
+6% +$1.88M 0.01% 1301
2013
Q2 		$32.5M Buy
+855,128
New +$30.6M 0.01% 1441

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock Institutional Trust's SRPT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Sarepta Therapeutics (SRPT) stake by 18% in Q4 2016, buying an estimated $8.01M and bringing the position to 1,306,520 shares worth $35.8M. The position accounts for 0.01% of the portfolio, ranked #1551.

BlackRock Institutional Trust first reported a position in SRPT in Q2 2013 and has held it in 15 quarters since. The position peaked at $68M in Q3 2016. 178 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

  • BlackRock Institutional Trust held 1,306,520 shares of Sarepta Therapeutics worth $35.8M as of Q4 2016.
  • BlackRock Institutional Trust bought 199,401 Sarepta Therapeutics shares in Q4 2016, an estimated $8.01M.
  • Sarepta Therapeutics made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1551 holding.
  • BlackRock Institutional Trust first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Sarepta Therapeutics position peaked at $68M in Q3 2016.
  • 178 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.